Eduardo Marichal, MD
Obstetrics & Gynecology · Gainesville, FLNPI 1720052103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 39.4% of the total. Reporting peaked in 2019 at $326 and has fallen 83.2% since, to $55 in 2025.
Across 57 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$427
- Bayer$137
- Astellas Pharma US Inc$132
- Hologic Sales And Service, LLC$85
- Therapeuticsmd, Inc.$43
- Minerva Surgical, Inc$36
- plus $224 from 10 others
What the payments were for
- Food & beverage$98691%
- Education$989%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $427 |
| Bayer | 8 | $137 |
| Astellas Pharma US Inc | 3 | $132 |
| Hologic Sales And Service, LLC | 6 | $85 |
| Therapeuticsmd, Inc. | 3 | $43 |
| Minerva Surgical, Inc | 1 | $36 |
| Sage Therapeutics, LLC | 2 | $32 |
| Exeltis, USA Inc. | 2 | $31 |
| Lupin Inc. | 2 | $31 |
| Roche Diagnostics Corporation | 2 | $24 |
| Organon | 1 | $22 |
| Millicent US Inc | 1 | $20 |
| Scynexis, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Myovant Sciences Inc. | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$1,084 in reported general payments places this provider in the 55th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,409 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Gainesville
- Bela KudishGainesville$59K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.